Much criticism of the U.S. Food and Drug Administration from health care analysts and commentators spotlights alleged overregulation of the medical realm and its adverse effects on both business growth and innovation.
The process applicable to formal rulemaking engaged in by federal agencies is lengthy and laborious. A recent Bloomberg article discussing how ideas turn into final administrative rules describes it as "cumbersome."
Given the bottom line linked with human lives and patient safety, it is hardly surprising that the health care realm is one of the most tightly regulated industries in the world.
Conscientious health care providers across New York -- doctors, nurses, pharmacists, lab technicians and others -- routinely think about care quality and how to best ensure that their patients are receiving it.
Health care "is complicated," stresses a recent New York Times article.
A recent study has shown that several states have expanded or enhanced their Medicaid benefits this year, with several planning to do so next year.
There is a strong reason why a New York doctor or physician's assistant might want to turn immediately for help to a proven doctors' rights law firm following receipt of an adverse communication -- indeed, virtually any communication -- from the New York Office of Professional Medical Conduct (OPMC).
Daniels, Porco & Lusardi, LLP, is a New York health care law firm that traces its roots back decades and has collective on-point experience over relevant client matters that spans well more than a century. As such, the firm's attorneys candidly know a thing or two about the close regulatory scrutiny that health care-related businesses routinely face.
Carole Faig, a regulatory expert focused on health care matters, concedes the sheer challenges and uncertainty that American medical industry actors routinely face as they seek to promote health and simultaneously prosper.
The New York State Department of Health made headlines earlier this week when it announced that the cultivation, production and sale of medical marijuana was going to be greatly expanded moving forward with the granting of licenses to five new firms.